Insights

Biosimilar Momentum Fresenius Kabi España operates within a global group actively expanding biosimilar portfolios, including rituximab and vedolizumab, signaling opportunities to cross-sell biosimilar manufacturing support, regulatory navigation, and hospital adoption programs for biologics.

Hospital Care Extend With a portfolio spanning infusion and transfusion technologies, critical care nutrition, and disposables, there is potential to upsell integrated hospital solutions such as infusion pumps, apheresis devices, and sterile disposables to capture broader hospital procurement needs.

Clinical Nutrition Growth A wide range of enteral and parenteral nutrition products positions sales opportunities in clinical nutrition corridors, including partnerships with ICU, oncology, and chronic care units seeking comprehensive nutrition support.

Similar companies to Fresenius Kabi España

Fresenius Kabi España Tech Stack

Fresenius Kabi España uses 8 technology products and services including Matomo, Power BI, Qlik, and more. Explore Fresenius Kabi España's tech stack below.

Media & News

Fresenius Kabi España's Email Address Formats

Fresenius Kabi España uses at least 4 email formats:
Fresenius Kabi España Email FormatsExamplePercentage
First.Last@fresenius-kabi.comJohn.Doe@fresenius-kabi.com
97%
Last.First@fresenius-kabi.comDoe.John@fresenius-kabi.com
1%
First.Middle@fresenius-kabi.comJohn.Michael@fresenius-kabi.com
1%
FirstLast@fresenius-kabi.comJohnDoe@fresenius-kabi.com
1%

Frequently Asked Questions

What is Fresenius Kabi España's official website and social media links?

Minus sign iconPlus sign icon
Fresenius Kabi España's official website is fresenius-kabi.com and has social profiles on LinkedIn.

How much revenue does Fresenius Kabi España generate?

Minus sign iconPlus sign icon
As of September 2026, Fresenius Kabi España's annual revenue is estimated to be $25M - $50M.

What is Fresenius Kabi España's NAICS code?

Minus sign iconPlus sign icon
Fresenius Kabi España's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Fresenius Kabi España have currently?

Minus sign iconPlus sign icon
As of September 2026, Fresenius Kabi España has approximately 196 employees across 2 continents, including Europe and North America. Key team members include Chief Financial Officer & Business Operations Director: M. P., Senior Director Marketing Pharma, Region International: M. Y. and Director: D. C. C. Explore Fresenius Kabi España's employee directory with LeadIQ.

What industry does Fresenius Kabi España belong to?

Minus sign iconPlus sign icon
Fresenius Kabi España operates in the Pharmaceutical Manufacturing industry.

What technology does Fresenius Kabi España use?

Minus sign iconPlus sign icon
Fresenius Kabi España's tech stack includes Matomo, Power BI, Qlik, Tableau, Salesforce Service Cloud, Splunk, SAP Ariba and Microsoft Teams.

What is Fresenius Kabi España's email format?

Minus sign iconPlus sign icon
Fresenius Kabi España's email format typically follows the pattern of First.Last@fresenius-kabi.com. Find more Fresenius Kabi España email formats with LeadIQ.
Fresenius Kabi España logo

Fresenius Kabi España

Pharmaceutical ManufacturingCatalonia, Spain51-200 Employees

Fresenius Kabi España is a pharmaceutical manufacturing company based in Barcelona, Catalonia, that focuses on providing products and services to hospital settings and home-based patient care. Its portfolio centers on medicines and infusion, transfusion, and clinical nutrition technologies, including bioequivalents and generic intravenous drugs, with a range that supports therapy and care for critical and chronic patients. The company serves healthcare professionals and hospital centers by delivering products and services that address everyday clinical challenges, while also supporting outpatient patient care at home. As part of the Fresenius Kabi global group, it operates within an international health services organization that emphasizes advancing patient care across more than 100 countries and thousands of employees worldwide. A recent development noted is Fresenius Kabi’s integration of TQ Therapeutics’ cell isolation technology into its Cue Cell Processing System, reflecting ongoing collaboration and expansion in its cell processing capabilities.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
51-200

Section iconFunding & Financials

  • $25M - $50M

    Fresenius Kabi España's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.